Publications by authors named "Akane Iguchi"
Background: Children with hypertrophic cardiomyopathy (HCM) have historically been considered to be high-risk candidates for general anaesthesia (GA), but there is currently a paucity of evidence regarding the safety of anaesthesia and perioperative outcomes in this population.
Methods: Clinical features and outcomes of all paediatric patients (<18 years) with HCM undergoing GA between 2000 and 2016 were reviewed.
Results: 86 patients (median 12.
We retrospectively reviewed the imaging findings, indications, technique and clinical impact in children who had undergone chest CT while undergoing extra-corporeal membrane oxygenation (ECMO). Radiology and ECMO databases were searched to identify all 19 children who had undergone chest CT (20 scans in total) while on ECMO at our institution between May 2003 and May 2012. We reviewed all CT scans for imaging findings.
View Article and Find Full Text PDFArticle Synopsis
- A retrospective study of patients who received extracorporeal life support from 1992 to 2010 aimed to analyze long-term survival rates and late mortality, with a focus on the most severely ill children.
- Out of 741 children, 36.7% experienced early deaths, while 6.2% faced late deaths, with a median follow-up of 7.1 years for survivors.
- Survival rates varied significantly by diagnosis, with the highest rates for meconium aspiration syndrome (88%) and the lowest for congenital heart disease (32%), with late deaths more common in those with complex conditions such as heart disease.
Perceived quality of life of children after successful bridging to heart transplantation.
J Heart Lung Transplant
April 2012
Background: Mechanical circulatory support is increasingly used to bridge children with end-stage heart failure to transplant. Quality of life (QoL) has not been systematically evaluated in children bridged to heart transplant.
Methods: All children transplanted for cardiomyopathy during 2001 to 2008 and currently being followed at our center (n = 84) had QoL assessed during 2006 to 2009, at a median of 3 years post-transplant, using a validated generic measure (PedsQL4.